Investigation of the Impact of CYP3A5 Polymorphism on Drug–Drug Interaction between Tacrolimus and Schisantherin A/Schisandrin A Based on Physiologically-Based Pharmacokinetic Modeling

Wuzhi capsule (WZC) is commonly prescribed with tacrolimus in China to ease drug-induced hepatotoxicity. Two abundant active ingredients, schisantherin A (STA) and schisandrin A (SIA) are known to inhibit CYP3A enzymes and increase tacrolimus’s exposure. Our previous study has quantitatively demonst...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Qingfeng, Bu, Fengjiao, Zhang, Hongyan, Wang, Qizhen, Tang, Zhijia, Yuan, Jing, Lin, Hai-Shu, Xiang, Xiaoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997453/
https://www.ncbi.nlm.nih.gov/pubmed/33673653
http://dx.doi.org/10.3390/ph14030198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7997453/
https://www.ncbi.nlm.nih.gov/pubmed/33673653
http://dx.doi.org/10.3390/ph14030198

Ejemplares similares